Daily Cleanse: 82% reporting less breakouts after 6-8 weeks** 97% were satisfied with their results** **Based on a survey of 29 subscribers who used Daily Cleanse for at least 3 months *These statements have not been evaluated by the Food and Drug Administration
Patients with T2DM, persons at risk for AD, had a significantly lower associated risk of AD after administered exenatide, liraglutide and dulaglutide ( Conclusion Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms in AD models, such as anti-inflammation, anti-oxidative stress, reducing A aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects
Maintenance dose: 0.75 to 4.5 mg subcutaneously once a week
PlexusDx provides compounded semaglutide injections ($189/mo), oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan), compounded tirzepatide injections ($289/mo), and oral tirzepatide ($349/mo) through licensed 503A pharmacies
Health and wellness 3.0 is a macrotrend shaping domestic consumer behaviors wherein consumers are focused on ones personal relationship with their body, and are much more knowledgeable about the foods they consume
